Author Archives: Omar Ford

Is med-tech really ready for total transparency?

Years ago at another publication, one of my former colleagues made one of the greatest rookie mistakes a person could make during their career. He triumphantly displayed how much money he was being paid to several reporters in the newsroom.

Share

Medtronic, the face of Med Tax opposition?

Don’t look now, but Medtronic has quite possibly just become the poster child of the opposition against the Medical Device Tax. During a call with analysts in February, the med-tech giant said that it expected to pay up to $175…

Share

Oops! … Roche did it again

It’s doubtful that Britney Spears’ 12-year-old hit single, Oops! . . . I did it again, entered into Roche’s mind when the firm disclosed a hostile takeover bid to acquire Illumina late last month for $44.50 a share in cash,…

Share

The medical device tax is coming

My wife and I are very cautious when we spend. Every penny is accounted for, and every surprise is documented. With a new baby in the household – we cannot afford any surprises that could possibly lead to longterm extra…

Share

Medtronic plans to enter ED market

Medtronic has the potential to be a trend setter with its attempt to have drug eluting stents (DES) treat erectile dysfunction (ED).

Share

Some paper along with those EHRs please …

Frustration could not even begin to describe the look on my mother’s face during a recent trip to a local lab here in Atlanta to get some diagnostic tests run.

Share

Could Medtronic eventually shed Infuse?

After Johnson & Johnson (J&J, New Brunswick, New Jersey) said that it was going to discontinue its work in the drug eluting stent (DES) market, my eyes then began to focus on Medtronic (Minneapolis), which has recently taken a beating…

Share

Trade Associations are life jackets for med-tech in age of uncertainty

Tuesday night during its quarterly meeting, the Southeastern Medical Device Association (SEMDA; Norcross, Georgia) unveiled its new logo and its new website, which is set to go live in the very near future.

Share

NLST results create huge opportunity for med-tech

Late last month, the American College of Radiology Imaging Network (ACRIN; Philadelphia) along with the National Cancer Institute’s Lung Screening Study Group released the results of the National Lung Screening Trial (NLST). The study supports the idea that CT Screening in older,…

Share

J&J exits DES market

A few weeks ago, I made the mistake of going into the gym around 6 p.m. That’s the time when all the body builders and athletes tend to circulate in the area.

Share

Marketo

Bad Behavior has blocked 344 access attempts in the last 7 days.